[从2018年到2022年对高伤心肌病研究的图书统计分析]
Tao Lu1, Zheng-Yang Lu1, Yan-Hai Meng1
1Adult Surgery Center,Fuwai Hospital,State Key Laboratory of Cardiovascular Disease,National Center for Cardiovascular Diseases,CAMS and PUMC,Beijing 100037,China.
超性心肌病 (HCM) 的研究表明,突然心脏死亡风险分层和预防是关键话题. 进步包括基因检测和药物 mavacamten,与美国领先的全球研究成果.
科学领域:
- 心脏病学 心脏病学
- 生物医学研究生物医学研究
更多相关视频
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
06:42Author Spotlight: Real-Time Measurements of Calcium and Contractility Parameters in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Published on: May 26, 2023
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Hypertension III: Clinical Manifestations and Diagnostic Studies
